Megan Dover

Co-Founder & Principal | Cross Border Impact Ventures

Megan Dover is Co-founder and Principal of Cross Border Impact Ventures (CBIV). At CBIV, she invests in Series A stage health technology companies in North America and Europe that address unmet needs for women and children globally. Key health focus areas for the fund include maternal & newborn health, sexual & reproductive health and chronic conditions that impact women and children such as oncology, cardiovascular health, neurological health, gut health and respiratory health.